Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Helmut Niller

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Future Microbiology|July 22, 2014
Role of epigenetics in EBV regulation and pathogenesisHans Helmut Niller, Zsófia Tarnai, Gábor Decsi, et al.
Reviews in Medical Virology|November 24, 2015
Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasmsHans Helmut Niller, Eva Ay, Ferenc Banati, et al.
AIDS Reviews|September 5, 2013
Epigenetics of HIV infection: promising research areas and implications for therapyEva Ay, Ferenc Banati, Maria Mezei, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomasMaria Takacs, Judit Segesdi, Ferenc Banati, et al.
The Journal of Biological Chemistry|August 23, 2003
Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiationMichael Rehli, Hans-Helmut Niller, Christoph Ammon, et al.
Biochimica Et Biophysica Acta|October 27, 2009
Epigenetic regulation of latent Epstein-Barr virus promotersMaria Takacs, Ferenc Banati, Anita Koroknai, et al.
Journal of Virology|March 22, 2002
Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomesHans Helmut Niller, Daniel Salamon, Jörg Uhlig, et al.
The Journal of General Virology|May 14, 2008
Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virusGyörgy Fejer, Anita Koroknai, Ferenc Banati, et al.
Medical Hypotheses|February 21, 2004
EBV-associated neoplasms: alternative pathogenetic pathwaysHans Helmut Niller, Daniel Salamon, Karin Ilg, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2002
Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacaeHans-Jörg Linde, Frank Notka, Christine Irtenkauf, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Future Microbiology|July 22, 2014
Role of epigenetics in EBV regulation and pathogenesisHans Helmut Niller, Zsófia Tarnai, Gábor Decsi, et al.
Reviews in Medical Virology|November 24, 2015
Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasmsHans Helmut Niller, Eva Ay, Ferenc Banati, et al.
AIDS Reviews|September 5, 2013
Epigenetics of HIV infection: promising research areas and implications for therapyEva Ay, Ferenc Banati, Maria Mezei, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomasMaria Takacs, Judit Segesdi, Ferenc Banati, et al.
The Journal of Biological Chemistry|August 23, 2003
Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiationMichael Rehli, Hans-Helmut Niller, Christoph Ammon, et al.
Biochimica Et Biophysica Acta|October 27, 2009
Epigenetic regulation of latent Epstein-Barr virus promotersMaria Takacs, Ferenc Banati, Anita Koroknai, et al.
Journal of Virology|March 22, 2002
Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomesHans Helmut Niller, Daniel Salamon, Jörg Uhlig, et al.
The Journal of General Virology|May 14, 2008
Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virusGyörgy Fejer, Anita Koroknai, Ferenc Banati, et al.
Medical Hypotheses|February 21, 2004
EBV-associated neoplasms: alternative pathogenetic pathwaysHans Helmut Niller, Daniel Salamon, Karin Ilg, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2002
Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacaeHans-Jörg Linde, Frank Notka, Christine Irtenkauf, et al.
Pageof 7